120 related articles for article (PubMed ID: 36586707)
1. Curcumin, a dietary natural supplement, prolongs the action potential duration of KCNE1-D85N-induced pluripotent stem cell-derived cardiomyocytes.
Martinez K; Smith A; Ye D; Zhou W; Tester DJ; Ackerman MJ
Heart Rhythm; 2023 Apr; 20(4):580-586. PubMed ID: 36586707
[TBL] [Abstract][Full Text] [Related]
2. Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome.
Kim M; Ye D; John Kim CS; Zhou W; Tester DJ; Giudicessi JR; Ackerman MJ
Circ Genom Precis Med; 2021 Jun; 14(3):e003234. PubMed ID: 34003017
[TBL] [Abstract][Full Text] [Related]
3. SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation.
Kim M; Sager PT; Tester DJ; Pradhananga S; Hamrick SK; Srinivasan D; Das S; Ackerman MJ
Heart Rhythm; 2023 Apr; 20(4):589-595. PubMed ID: 36610526
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
[TBL] [Abstract][Full Text] [Related]
5. D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome.
Nishio Y; Makiyama T; Itoh H; Sakaguchi T; Ohno S; Gong YZ; Yamamoto S; Ozawa T; Ding WG; Toyoda F; Kawamura M; Akao M; Matsuura H; Kimura T; Kita T; Horie M
J Am Coll Cardiol; 2009 Aug; 54(9):812-9. PubMed ID: 19695459
[TBL] [Abstract][Full Text] [Related]
6. KCNE1 D85N polymorphism--a sex-specific modifier in type 1 long QT syndrome?
Lahtinen AM; Marjamaa A; Swan H; Kontula K
BMC Med Genet; 2011 Jan; 12():11. PubMed ID: 21244686
[TBL] [Abstract][Full Text] [Related]
7. Patient-specific, re-engineered cardiomyocyte model confirms the circumstance-dependent arrhythmia risk associated with the African-specific common SCN5A polymorphism p.S1103Y: Implications for the increased sudden deaths observed in black individuals during the COVID-19 pandemic.
Hamrick SK; John Kim CS; Tester DJ; Giudicessi JR; Ackerman MJ
Heart Rhythm; 2022 May; 19(5):822-827. PubMed ID: 34979239
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies.
Stutzman MJ; Gao X; Kim M; Ye D; Zhou W; Tester DJ; Giudicessi JR; Shannon K; Ackerman MJ
Heart Rhythm; 2023 May; 20(5):709-717. PubMed ID: 36731785
[TBL] [Abstract][Full Text] [Related]
9. Elevation of propofol sensitivity of cardiac I
Kojima A; Mi X; Fukushima Y; Ding WG; Omatsu-Kanbe M; Matsuura H
Br J Pharmacol; 2021 Jul; 178(13):2690-2708. PubMed ID: 33763865
[TBL] [Abstract][Full Text] [Related]
10. Injectable contraceptive Depo-Provera induces erratic beating patterns in patient-specific induced pluripotent stem cell-derived cardiomyocytes with long QT syndrome type 2.
Pinsky AM; Gao X; Bains S; Kim CJ; Louradour J; Odening KE; Tester DJ; Giudicessi JR; Ackerman MJ
Heart Rhythm; 2023 Jun; 20(6):910-917. PubMed ID: 36889623
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
[TBL] [Abstract][Full Text] [Related]
12. Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant.
Garg P; Oikonomopoulos A; Chen H; Li Y; Lam CK; Sallam K; Perez M; Lux RL; Sanguinetti MC; Wu JC
J Am Coll Cardiol; 2018 Jul; 72(1):62-75. PubMed ID: 29957233
[TBL] [Abstract][Full Text] [Related]
13. Genome sequencing in a genetically elusive multigenerational long QT syndrome pedigree identifies a novel LQT2-causative deeply intronic KCNH2 variant.
Tobert KE; Tester DJ; Zhou W; Haglund-Turnquist CM; Giudicessi JR; Ackerman MJ
Heart Rhythm; 2022 Jun; 19(6):998-1007. PubMed ID: 35144019
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5.
Thomas G; Killeen MJ; Gurung IS; Hakim P; Balasubramaniam R; Goddard CA; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):99-114. PubMed ID: 17095567
[TBL] [Abstract][Full Text] [Related]
15. Instability of KCNE1-D85N that causes long QT syndrome: stabilization by verapamil.
Sakata S; Kurata Y; Li P; Notsu T; Morikawa K; Miake J; Higaki K; Yamamoto Y; Yoshida A; Shirayoshi Y; Yamamoto K; Horie M; Ninomiya H; Kanzaki S; Hisatome I
Pacing Clin Electrophysiol; 2014 Jul; 37(7):853-63. PubMed ID: 24499369
[TBL] [Abstract][Full Text] [Related]
16. Disrupted Ca
Kashiwa A; Makiyama T; Kohjitani H; Maurissen TL; Ishikawa T; Yamamoto Y; Wuriyanghai Y; Gao J; Huang H; Imamura T; Aizawa T; Nishikawa M; Chonabayashi K; Mishima H; Ohno S; Toyoda F; Sato S; Yoshiura KI; Takahashi K; Yoshida Y; Woltjen K; Horie M; Makita N; Kimura T
Heart Rhythm; 2023 Jan; 20(1):89-99. PubMed ID: 36007726
[TBL] [Abstract][Full Text] [Related]
17. SGK1 inhibition attenuated the action potential duration in patient- and genotype-specific re-engineered heart cells with congenital long QT syndrome.
Kim M; Das S; Tester DJ; Pradhananga S; Hamrick SK; Gao X; Srinivasan D; Sager PT; Ackerman MJ
Heart Rhythm O2; 2023 Apr; 4(4):268-274. PubMed ID: 37124559
[TBL] [Abstract][Full Text] [Related]
18. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
[TBL] [Abstract][Full Text] [Related]
19. Long QT syndrome type 5-Lite: Defining the clinical phenotype associated with the potentially proarrhythmic p.Asp85Asn-KCNE1 common genetic variant.
Lane CM; Giudicessi JR; Ye D; Tester DJ; Rohatgi RK; Bos JM; Ackerman MJ
Heart Rhythm; 2018 Aug; 15(8):1223-1230. PubMed ID: 29625280
[TBL] [Abstract][Full Text] [Related]
20. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2.
Giannetti F; Barbieri M; Shiti A; Casini S; Sager PT; Das S; Pradhananga S; Srinivasan D; Nimani S; Alerni N; Louradour J; Mura M; Gnecchi M; Brink P; Zehender M; Koren G; Zaza A; Crotti L; Wilde AAM; Schwartz PJ; Remme CA; Gepstein L; Sala L; Odening KE
Europace; 2023 May; 25(5):. PubMed ID: 37099628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
